These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35094480)

  • 21. A case of dirty neck in severe and diffuse atopic dermatitis successfully treated with dupilumab.
    Patruno C; Ferrillo M; Fabbrocini G; Napolitano M
    Dermatol Ther; 2021 Jan; 34(1):e14556. PubMed ID: 33205854
    [No Abstract]   [Full Text] [Related]  

  • 22. Effective treatment of atopic dermatitis with dupilumab in an HIV-positive patient.
    Olbricht N; Kromer C; Forkel S; Schön MP; Buhl T
    J Dtsch Dermatol Ges; 2020 Dec; 18(12):1488-1490. PubMed ID: 32909372
    [No Abstract]   [Full Text] [Related]  

  • 23. Improvement of atopic dermatitis and IgA nephropathy in a patient treated by dupilumab.
    Tanczosova M; Arenberger P; Rychlik I; Arenbergerova M; Gkalpakiotis S
    Dermatol Ther; 2021 Jan; 34(1):e14708. PubMed ID: 33368910
    [No Abstract]   [Full Text] [Related]  

  • 24. Dupilumab ocular surface disease occurs predominantly in patients receiving dupilumab for atopic dermatitis: A multi-institution retrospective chart review.
    Waldman RA; DeWane ME; Sloan SB; King B; Grant-Kels JM
    J Am Acad Dermatol; 2021 Sep; 85(3):735-736. PubMed ID: 31325553
    [No Abstract]   [Full Text] [Related]  

  • 25. Dupilumab for the treatment of atopic dermatitis in transplant patients: Two case reports and literature review.
    Napolitano M; Nocerino M; Picone V; Martora F; Fabbrocini G; Dastoli S; Patruno C
    Dermatol Ther; 2022 Apr; 35(4):e15324. PubMed ID: 35048522
    [No Abstract]   [Full Text] [Related]  

  • 26. Dupilumab facial redness: Clinical characteristics and proposed treatment in a cohort.
    Ordóñez-Rubiano MF; Casas M; Balaguera-Orjuela V
    Dermatol Ther; 2021 Nov; 34(6):e15140. PubMed ID: 34549488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of lichen amyloidosis associated with atopic dermatitis successfully treated with dupilumab: A case report and literature review.
    Aoki K; Ohyama M; Mizukawa Y
    Dermatol Ther; 2021 Jul; 34(4):e15005. PubMed ID: 34037298
    [No Abstract]   [Full Text] [Related]  

  • 28. Dupilumab-induced serum sickness-like reaction: an unusual adverse effect in a patient with atopic eczema.
    Treudler R; Delaroque N; Puder M; Simon JC; Szardenings M
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):e30-e32. PubMed ID: 32594596
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful Treatment of Atopic Dermatitis with Dupilumab in a Patient with Non-Hodgkin's Lymphoma.
    Qiu Y; Ali K; Lou H; Shan J; Wu L
    Acta Derm Venereol; 2022 Jan; 102():adv00625. PubMed ID: 34904683
    [No Abstract]   [Full Text] [Related]  

  • 30. Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis.
    Marcant P; Balayé P; Merhi R; Jendoubi F; Nosbaum A; Raison-Peyron N; Du-Thanh A; Lasek A; Ferrier le Bouedec MC; Tetart F; Valois A; Barbarot S; Soria A; Jachiet M; Staumont-Sallé D;
    J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):e394-e396. PubMed ID: 33594731
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term safety of combined biological therapy in a patient affected by arthropathic psoriasis and atopic dermatitis.
    Balestri R; Magnano M; Girardelli CR; Bortolotti R; Rech G
    Dermatol Ther; 2020 Jul; 33(4):e13498. PubMed ID: 32359110
    [No Abstract]   [Full Text] [Related]  

  • 32. [Psoriasis in dupilumab-treated atopic dermatitis].
    Senner S; Eicher L; Aszodi N; Prinz JC; French LE; Wollenberg A
    Hautarzt; 2020 May; 71(5):383-386. PubMed ID: 32179945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Success of dupilumab as a monotherapy in an adult patient affected by severe uncontrolled asthma and atopic dermatitis.
    Tolino E; Proietti I; Sarni A; Bernardini N; Mambrin A; Balduzzi V; Maddalena P; Marchesiello A; Michelini S; Volpe S; Skroza N; Potenza C
    Dermatol Ther; 2021 Jan; 34(1):e14596. PubMed ID: 33244860
    [No Abstract]   [Full Text] [Related]  

  • 34. Difference in the rate of ocular adverse events with dupilumab between asthma and atopic dermatitis patients.
    Wang Y; Jorizzo J
    Int J Dermatol; 2021 Sep; 60(9):e382. PubMed ID: 33715168
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study.
    Nakahara T; Kido-Nakahara M; Onozuka D; Sakai S; Hirose T; Take N; Sugiyama A; Harada K; Tsuji G; Kikuchi S; Kohda F
    Acta Derm Venereol; 2021 Nov; 101(11):adv00586. PubMed ID: 34708248
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
    Bosma AL; de Wijs LEM; Hof MH; van Nieuwenhuizen BR; Gerbens LAA; Middelkamp-Hup MA; Hijnen D; Spuls PI
    J Am Acad Dermatol; 2020 Nov; 83(5):1375-1384. PubMed ID: 32485210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A paradoxical head and neck erythema: an adverse event due to dupilumab in adult patients with atopic dermatitis.
    Russo F; Rizzo A; Santi F; Lamberti A; Lazzeri L; Flori ML; Rubegni P
    Int J Dermatol; 2022 Jun; 61(6):e204-e206. PubMed ID: 34480761
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased expression of interleukin-23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment.
    Napolitano M; Caiazzo G; Fabbrocini G; Balato A; Di Caprio R; Scala E; Scalvenzi M; Patruno C
    Br J Dermatol; 2021 Feb; 184(2):341-343. PubMed ID: 33533476
    [No Abstract]   [Full Text] [Related]  

  • 39. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
    Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
    BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superimposed linear atopic dermatitis treated with dupilumab.
    Leszczynska MA; Trainor MA; Henkel E; Keeling BH; Diaz LZ
    Pediatr Dermatol; 2021 Sep; 38(5):1377-1378. PubMed ID: 34272754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.